Announcements

  • A diverse group of people

    This ongoing Series of articles highlights the importance of a more diverse, equitable and inclusive cardiovascular workforce in improving the quality of patient care and scientific research.

  • Computer circuit board representing metabolic pathways

    This ongoing Series of articles from Nature Reviews Cardiology covers all aspects of cardiometabolism, including the role of metabolism in cardiovascular physiology, metabolic remodelling in cardiovascular and cardiometabolic diseases, and novel and potential preventative and therapeutic strategies targeting metabolic pathways.

Advertisement

  • Data from the ARIES-HM3 trial show that excluding aspirin from the antithrombotic regimen in patients with advanced heart failure and a left ventricular assist device reduces the number of bleeding events and does not increase the risk of thromboembolism.

    • Gregory B. Lim
    Research Highlight
  • Activation of a specific set of vagal sensory neurons connecting the ventricular wall of the heart to the area postrema in the brainstem causes mice to faint. This finding defines a cardiac reflex that recapitulates characteristics of human syncope.

    • Gregory B. Lim
    Research Highlight
  • Two new studies using cryo-electron microscopy describe the structure and conformation of myosin in the cardiac thick filaments and how it interacts with other thick-filament proteins, such as titin and cardiac myosin-binding protein C, in mammalian hearts.

    • Gregory B. Lim
    Research Highlight
  • Treatment with the small interfering RNA patisiran preserves functional capacity and improves health status and quality of life in patients with transthyretin cardiac amyloidosis, according to data from the 12-month double-blind period of the ongoing APOLLO-B trial.

    • Irene Fernández-Ruiz
    Research Highlight

Anticoagulants

Anticoagulant drugs are used to prevent and treat thrombotic disorders in millions of patients worldwide. This Milestone plots the history of anticoagulant drugs, starting with the discovery and clinical trials of heparin and warfarin.
Milestone

Advertisement

Nature Careers

Science jobs

Advertisement